Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAge Labs (BIOA) Net Cash Flow (2024 - 2025)

BioAge Labs (BIOA) has disclosed Net Cash Flow for 2 consecutive years, with -$26.7 million as the latest value for Q4 2025.

  • Quarterly Net Cash Flow fell 235.1% to -$26.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$165.4 million through Dec 2025, down 150.22% year-over-year, with the annual reading at -$165.4 million for FY2025, 150.22% down from the prior year.
  • Net Cash Flow hit -$26.7 million in Q4 2025 for BioAge Labs, down from -$4.7 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $175.4 million in Q3 2024 to a low of -$96.9 million in Q1 2025.